Phase II study of gefitinib for the treatment of recurrent and metastatic nasopharyngeal carcinoma

Head & Neck
D ChuaGordon K H Au

Abstract

This single-center, phase II study assessed the safety/tolerability and initial efficacy of gefitinib in patients with nasopharyngeal carcinoma (NPC) pretreated with platinum-based chemotherapy. Patients with recurrent and metastatic NPC who had treatment failure with at least 2 lines of chemotherapy including platinum were given gefitinib at a fixed dose of 250 mg daily. Treatment was continued until the patient experienced unacceptable side effects or disease progression. Nineteen patients were enrolled, having had treatment failure with a median of 2 chemotherapy regimens. Treatment was well tolerated, and only grades 1 to 2 adverse events were observed. None of the patients achieved partial or complete response. Median time-to-progression was 4 months, and median overall survival was 16 months. Gefitinib was well tolerated, but the response rate was poor in this heavily pretreated study population, and its use in NPC is not recommended outside the context of clinical trial.

References

Mar 10, 1999·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·W YeoP J Johnson
Mar 15, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A FandiE Cvitkovic
Apr 14, 2000·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·D T ChuaD Choy
Aug 16, 2002·Annals of Oncology : Official Journal of the European Society for Medical Oncology·R K C NganK C Tse
May 14, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ezra E W CohenEverett E Vokes
May 16, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Masahiro FukuokaJosé Baselga
Dec 3, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Ezra E W CohenEverett E Vokes
Dec 21, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jennifer A ChanCharles S Fuchs

❮ Previous
Next ❯

Citations

Oct 15, 2010·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A T C Chan
Feb 4, 2010·Anti-cancer Drugs·Francesco CaponigroFrancesco Perri
Feb 23, 2010·Current Opinion in Oncology·Albiruni R A RazakChristophe Le Tourneau
Feb 14, 2013·Drug Design, Development and Therapy·Lu ZhangHai-Qiang Mai
Dec 18, 2013·Oral Oncology·Alan K S ChiangWai Tong Ng
Nov 19, 2013·Current Treatment Options in Oncology·S D StokerI B Tan
Jan 28, 2014·Oral Oncology·Janice TsangDora L W Kwong
Feb 9, 2012·Expert Opinion on Therapeutic Targets·Stephen L Chan, Brigette B Ma
Mar 11, 2010·Expert Review of Anticancer Therapy·Belisario A ArangoEdgardo S Santos
Sep 24, 2008·Expert Opinion on Investigational Drugs·Judith Loeffler-RaggHeinz Zwierzina
Jun 19, 2010·Expert Opinion on Emerging Drugs·Christopher Fung, Jennifer R Grandis
Oct 8, 2013·Expert Opinion on Emerging Drugs·Paolo BossiLisa Licitra
Sep 4, 2012·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Anne W M LeeT H Lam
May 11, 2010·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Albiruni R A RazakKelvin Chan
Jan 20, 2010·Current Problems in Cancer·Helen X ChenJanet E Dancey
Oct 17, 2015·International Journal of Radiation Biology·Ting LinGang Peng
Nov 23, 2011·Head & Neck·Bo HongAnthony Tak-Cheung Chan
Aug 22, 2015·Journal of Cranio-maxillo-facial Surgery : Official Publication of the European Association for Cranio-Maxillo-Facial Surgery·J Y ChenY X Zhu
May 13, 2015·Chinese Journal of Cancer·Jian-Wei ZhangLi Zhang
Aug 5, 2015·Anti-cancer Drugs·Francesco PerriSalvatore Pisconti
May 18, 2013·Asian Pacific Journal of Cancer Prevention : APJCP·Wei-Guang GuShu-Sen Wang
Dec 24, 2010·European Annals of Otorhinolaryngology, Head and Neck Diseases·Y BensoudaH Errihani
Mar 21, 2019·Current Opinion in Oncology·Esma Saada-BouzidJoël Guigay
May 30, 2013·American Society of Clinical Oncology Educational Book·Amanda PsyrriAntonio Jimeno
Nov 18, 2017·Japanese Journal of Clinical Oncology·Wai Tong NgAnne W M Lee
Jun 30, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Wan-Teck LimEng-Huat Tan
Oct 24, 2020·Signal Transduction and Targeted Therapy·Yuanbo KangLei Wang
Jul 2, 2021·Nature Reviews. Clinical Oncology·Kenneth C W WongAnthony T C Chan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.